Thu, Jul 10, 2014, 2:48 PM EDT - U.S. Markets close in 1 hr 12 mins

Recent

% | $
Quotes you view appear here for quick access.

Amylin Pharmaceuticals, Inc. Message Board

  • terry_amln terry_amln May 26, 2012 10:12 AM Flag

    Bloomberg slant $25 bid

    The bids were taken with a MINIMUM bid of $25 to set a floor, so naturally those who want to buy more stock twist this as if that would be a bid Amylin would accept.Its nonsense.That is the price Carl Icahn is up just 15%,and if you think that after 4 years and the holder of the most innovative drug in diabetes would take such a paltry amount well,then please sell.
    Carl Icahn told Amylin shareholders 3 years ago (after many here complained that LLY had a crony put on the board) that he would NEVER sell at a low price.Icahn will sell at a FAIR price.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The bids were taken with a MINIMUM bid of $25 to set a floor, so naturally those who want to buy more stock twist this as if that would be a bid Amylin would accept.Its nonsense.That is the price Carl Icahn is up just 15%,and if you think that after 4 years and the holder of the most innovative drug in diabetes would take such a paltry amount well,then please sell.
      Carl Icahn told Amylin shareholders 3 years ago (after many here complained that LLY had a crony put on the board) that he would NEVER sell at a low price.Icahn will sell at a FAIR price.

      • 1 Reply to terry_amln
      • Try not to confuse fact with the pump and dump rumours which have recently been circulating.

        1. We know that the BMY offer was "not material" - therefor it could not have entailed shareholders receiving a significant premium to the share price at the time ($16 or less).

        2. If the BOD had spent shareholder money on engaging the services of consultant firms to conduct an auction of the business the shareholders chose to invest in - the BOD would have been obliged to tell shareholders what they were doing.

    • Carl himself said on CNBC that he would be happy with $29 at one point.
      Not everything that Carl invests will need to make mega bucks. He probably will be happy to take $29 rather than $14 this stock traded after FDA approval (or much lower before the approval)

    • Some of the posts on this message board are so uninformed.The $25 opening bids accepted is to make it clear that BMY and others that think Amylin could possible get sold for $25 or $28 or whatever brokerages traders and insiders want you to believe while they buy more shares.

    • This begs the question what would Icahn do, after all the bids are in(1st round, 2nd round, nth round), the highest is in $32-35 area? Would he let the current board/ management continue to mismanage the company and risk his investment down the road or take less than desired profit and move on? I would categorically say it would be the latter. JMO.

      • 1 Reply to gjjagan
      • no question he sells at anything over 30. I think the way the stock settled on Friday the higher of the 2 bids is at 28. another 15-20% is all that is needed to get this thing to the finish line and anything above that is gravy for the board and big shareholders. no way they let this management continue to drive the bus, they've shown they have no clue how to run a company

        GLTAL

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.